Avacta Group Plc (LON:AVCT – Get Free Report) traded up 11.2% during trading on Thursday . The stock traded as high as GBX 50.65 ($0.64) and last traded at GBX 49.21 ($0.62). 1,038,627 shares changed hands during mid-day trading, a decline of 56% from the average session volume of 2,346,237 shares. The stock had previously closed at GBX 44.25 ($0.56).
Avacta Group Trading Up 10.8 %
The company’s 50 day moving average is GBX 55.55 and its two-hundred day moving average is GBX 57.41. The company has a debt-to-equity ratio of 63.54, a current ratio of 1.29 and a quick ratio of 4.96. The firm has a market cap of £175.75 million, a P/E ratio of -491.67 and a beta of 1.12.
Insiders Place Their Bets
In other news, insider Tony Peter Gardiner sold 500,000 shares of Avacta Group stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of GBX 71 ($0.90), for a total transaction of £355,000 ($449,196.51). Company insiders own 32.90% of the company’s stock.
About Avacta Group
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Recommended Stories
- Five stocks we like better than Avacta Group
- How to Use the MarketBeat Excel Dividend Calculator
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Why Invest in 5G? How to Invest in 5G Stocks
- Williams-Sonoma Stock: Buy It and Never Let It Go
- 3 REITs to Buy and Hold for the Long Term
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
